You get it and others but some people don’t get it.
Company is growing and they aren’t targeting gradual revenue growth they are targeting major revenue growth. There is PR in place for key management to deliver us substantial revenue which would either eliminate or drastically reduce the cash burn with the timeframe.
This deal is potentially worth millions in revenue each year when it launches but if people want to sit out and wait for the revenue that is okay but it will be at a premium when it comes in if they want to rejoin when revenue is logged.
Yes there could be a raise in 12 months time but that would require the business to do absolutely nothing for 12 months and not launch the hubs that have been announced or sign on new deals etc - this won’t happen because management are proactive and super keen to get their PR and also Gernot holds 20M shares and quit working at TSN earlier this year to focus on Mogul so he clearly won’t let this baby he has fully invested in go silly.
- Forums
- ASX - By Stock
- LU7
- Ann: Mineski Enters Strategic Partnership with Mogul
Ann: Mineski Enters Strategic Partnership with Mogul, page-35
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LU7 (ASX) to my watchlist
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.502M |
Open | High | Low | Value | Volume |
1.7¢ | 1.7¢ | 1.6¢ | $12.13K | 731.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1042529 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 200661 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1042529 | 0.016 |
6 | 1032233 | 0.015 |
6 | 509173 | 0.014 |
7 | 1443922 | 0.013 |
3 | 682500 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 200661 | 3 |
0.018 | 386519 | 3 |
0.019 | 2201904 | 2 |
0.020 | 1482273 | 5 |
0.021 | 550000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LU7 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online